Tim Van Hauwermeiren

Actionable Insights Powered by AI

Argenx Appoints Karen Massey as New CEO in Leadership Transition

argenx; Karen Massey; CEO; Tim Van Hauwermeiren; leadership transition; rare diseases; Vyvgart